-
-
公开(公告)号:JPH0552841B2
公开(公告)日:1993-08-06
申请号:JP23311885
申请日:1985-10-18
申请人: CHOAY SA
发明人: JANNKUROODO RORUMOO , JAN SHOAI
IPC分类号: A61K31/715 , A61K38/01 , A61P7/02 , C08B37/00 , C08B37/10 , A61K31/725
摘要: The method for producing the biologically active mucopolysaccharides comprises the treatment of heparin with depolymerizing agent followed by the separation of the end-product by ethanol precipitation. Sodium nitrite is used as depolymerizing agent. Heparin is used at the concentration of 5 mass %, sodium nitrite – 0.0435 M. The incubation is performed at pH 2.5 until NO-2 ions are no longer detectable. Prior to the separation of the end-product, pH of the reaction mixture is adjusted to 7 with sodium hydroxide solution. Ethanol is added at a 2:1 ratio to the reaction mixture. The precipitate is re-dissolved in the aqueous solution of NaCl at pH 3.8.
-
公开(公告)号:JPH04230633A
公开(公告)日:1992-08-19
申请号:JP16487491
申请日:1991-07-05
申请人: IMMUNO AG
发明人: EIBL JOHANN , PICHLER LUDWIG , SCHWARZ HANS-PETER
IPC分类号: A61K38/43 , A61K35/16 , A61K38/00 , A61K38/01 , A61K38/17 , A61K38/46 , A61K38/48 , A61P1/00 , A61P9/00 , A61P9/14 , A61P13/02 , A61P15/00 , A61P25/02 , A61P25/04 , A61P29/00 , A61P37/00 , C07K16/40 , C12N9/64
摘要: PURPOSE: To use a protein C and an activated protein C as a pharmaceutical preparation containing the protein C or the activated protein C and useful for treatment of pain caused by inflammatory process. CONSTITUTION: A preparation containing a protein C or an activated protein C is used for treatment of pain in a state after trauma and operation, and primary and secondary malignancy disease, treatment of pain in chronicity arthrorheumatism, myocarditis, gastritis, enteritis and inflammation in urethra, or treatment of pain in acute or chronic inflammatory process accompanied with explant refusal based on anti-nociceptive effects. The preparation is also useful for treatment of the before inflammatory process. A formulated preparation including at least one anti-inflammatory agent and/or analgesic in combination shows a synergetic effect.
-
公开(公告)号:JPH04183371A
公开(公告)日:1992-06-30
申请号:JP30950490
申请日:1990-11-15
IPC分类号: A23C20/00 , A23J3/08 , A23J3/34 , A23L33/16 , A23L33/17 , A23L33/19 , A61K33/06 , A61K38/00 , A61K38/01 , A61K38/17 , A61P19/10 , A61P43/00 , C12P21/06
摘要: PURPOSE:To prepare a bone-fortifying food, pharmaceutical or feed enabling the absorption of large amounts of whey protein and peptide and effective for fortifying the bone by using a water-soluble fraction of whey protein as a component. CONSTITUTION:Whey is a transparent yellowish green liquid obtained as a by-product of a cheese or casein preparation process and produced by adding an acid or rennet to milk or defatted milk and removing the coagulum from the mixture. Whey protein is a water-soluble protein produced by the ultrafiltration, reverse osmosis, chromatography, dialysis, etc., of the whey. The protein to be used in the present product is preferably a water-soluble fraction of a whey protein having a molecular weight of 10,000-45,000 and an isoelectric point of PI 3-8. In the case of performing an enzymatic decomposition with a proteinase, the solution or suspension of the protein is added with a proteinase and subjected to enzymatic decomposition. A proteinase- decomposition product having a molecular weight of about 20,000-300 can be produced by adjusting the solution or suspension of the protein to the optimum pH and optimum temperature for the enzyme, adding the enzyme to the solution, etc., and subjecting the solution to enzymatic reaction for a prescribed time in a stationary state or under stirring.
-
75.
公开(公告)号:JPH04144678A
公开(公告)日:1992-05-19
申请号:JP18925290
申请日:1990-07-17
申请人: YAN CHIENHOA
发明人: YAN CHIENHOA
IPC分类号: A23L33/17 , A23J3/16 , A23L33/135 , A61K38/00 , A61K38/01 , A61K38/16 , A61P1/04 , A61P7/00 , A61P7/06 , A61P35/00 , C12N1/00 , C12N1/20 , C12N1/21 , C12R1/38 , A23L1/305 , A61K37/18
摘要: This invention relates to a mutant pseudomonas identified as strain YZH and the use of the strain by means of a fermentation process to produce a single cell protein nutrient solution from plant protein . The resulting nutrient solution is suitable as food for animals and human , and has salutory effects on animals and human such as reducing bleeding of the gastric mucosa , stimulating and improving hemogenesis and inhibiting cancer cell growth and traversing the cancer cell into its normal cell. The main characteristics of the strain YZH are that it is a rod in light yellow color , has at lease one flagellum , has the ability to reduce nitrate and to liquidize gelatine , is not able to produce water soluble pigment , and to form poly- beta -hydroxy butyrate and in particular , has a Y fragment in its DNA which is detectable by means of a specific Y fragment DNA probe.
-
公开(公告)号:JPH0469315A
公开(公告)日:1992-03-04
申请号:JP18234390
申请日:1990-07-09
IPC分类号: A23L3/3472 , A23J3/34 , A61K8/00 , A61K8/64 , A61K8/96 , A61K38/00 , A61K38/01 , A61K38/17 , A61K38/55 , A61P17/00 , A61Q19/02 , C12N9/99 , C12P21/00
摘要: PURPOSE:To obtain a safe and stable tyrosinase-inhibitor usable for foods and pharmaceuticals by using a hydrolyzed milk protein existing in milk such as casein or whey protein as an active component. CONSTITUTION:The objective tyrosinase-inhibitor contains a hydrolyzed product of a milk protein (not necessarily contain lactoferrin) as an active component. The amount of the active component is preferably >=0.05wt.%. The decomposition degree of the hydrolyzed milk protein is preferably >=6wt.%. The hydrolyzed product used in the present agent is very stable to heat, pH, oxidation, etc., and is composed of a mixture of peptides having various molecular weights. It can be advantageously used as an additive for foods, cosmetics and pharmaceuticals.
-
公开(公告)号:JPH03187348A
公开(公告)日:1991-08-15
申请号:JP26490090
申请日:1990-10-01
发明人: JIYANNMOORISU KAAN , FURANSOWA MANDEII , ROI ROGAA
摘要: PURPOSE: To obtain an org. product which contains amino acids in the form of oligopeptide refined by hydrolyzing whey protein, does not contain a protein of a specific mol.wt., ensures absorption and does not contain allergen. CONSTITUTION: Protein whey factions of soybean protein, etc., are prepd. as an aq. soln. and are subjected to prehydrolysis with pepsin preferably at pH2 to 3. These fractions are then subjected to enzymatically hydrolysis with tripsn- chymotrispsin and are ultrafiltered, concentrated and dried, by which the desired product contg. the amino acid as the ologipeptide form having 4 to 10 amino acids at a ratio of 40 to 60wt.% without contg. the protein of the mol.wt. of >=60000 is obtd.
-
公开(公告)号:JPH01187067A
公开(公告)日:1989-07-26
申请号:JP25538387
申请日:1987-10-09
申请人: KANEBO LTD
发明人: SUETSUNA KUNIO , MURAKAMI UMEJI , SUGAI RYUJI , TAKEMOTO TAIRA
IPC分类号: A23L1/305 , A23L33/115 , A23L33/17 , A23L33/19 , A61K35/54 , A61K35/57 , A61K38/00 , A61K38/01 , A61K38/08 , A61K38/10 , A61K38/17 , A61K38/55 , A61P9/12
摘要: PURPOSE:To form an oral intake composition useful as a healthy food for preventing hypertension and alleviating hypertensive tendency, by using inhibitory peptide of angiotensin converting enzyme derived from casein and egg yolk. CONSTITUTION:An oral intake composition containing a peptide inhibiting angiotensin converting enzyme(ACE for short) obtained by decomposing casein with protease and egg yolk. The peptide inhibiting ACE is usually isolated in the form of powder, blended with egg yolk and used as it is or preferably as a composition in any shape or configuration together with a proper nontoxic carrier for oral administration. Egg yolk of egg of chicken, quail, ostrich, etc., sold in the market can be used as the egg yolk. Total content of the inhibitory peptide of ACE and egg yolk is generally about 1-100wt%. and the ratio of the above-mentioned peptide and the egg yolk is generally about 1:10-3:1.
-
公开(公告)号:JPH0124137B2
公开(公告)日:1989-05-10
申请号:JP5964581
申请日:1981-04-20
发明人: KAYO ERIKUSON
IPC分类号: A23J1/06 , A23J3/34 , A23L1/305 , A61K33/26 , A61K38/00 , A61K38/01 , A61K38/16 , C07K14/795 , C07K14/805
-
-
-
-
-
-
-
-
-